Eric Henry’s Post

View profile for Eric Henry, graphic

MedTech Industry Leader

How do you define "transparency" in AI/ML-enabled medical devices? An article published in Nature on 26 January looks back to a workshop held by FDA in 2021 to answer this question from the perspectives of a variety of stakeholders (i.e., patients, healthcare providers, payors, and industry). The money shot is Table 1 (below), which summarizes what each stakeholder views as key considerations when thinking of transparency. You can click the link above the table to view the entire article: https://lnkd.in/gP28Tyzx Thanks to timothy w hsu for sending the article to me.

Table 1 Important transparency considerations expressed at the workshop.

Table 1 Important transparency considerations expressed at the workshop.

nature.com

Evan Schnell

Director of Software at Synchron

8mo

Thanks for sharing, this is a really nice summary of the considerations in play.

Like
Reply

To view or add a comment, sign in

Explore topics